This is a preview of subscription content, log in via an institution to check access.
Reference
Lipska I, et al. Does conditional approval for new oncology drugs in Europe lead to differences in health technology assessment decisions? Clinical Pharmacology and Therapeutics : 6 Aug 2015. Available from: URL: http://doi.org/10.1002/cpt.198
Rights and permissions
About this article
Cite this article
Conditional approval has no impact on HTA decisions. PharmacoEcon Outcomes News 735, 9 (2015). https://doi.org/10.1007/s40274-015-2383-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2383-4